Error: Could not add to watchlist. X

CFS Managed Investment Fund - Global Health & Biotechnology

+ Watchlist
COLFHLB:AU
1.9638
AUD
0.0032
0.16%
As of 12:59 AM EST on 2/9/2016.
Fund Type
Unit Trust
52Wk Range
1.9606 - 2.4791
1 Yr Return
-2.51%
YTD Return
-15.84%
Previous Close
1.9606
52Wk Range
1.9606 - 2.4791
1 Yr Return
0.33%
YTD Return
-15.84%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 02/09/2016)
1.9638
Total Assets (m AUD) (on 12/31/2015)
28.845
Inception Date
04/28/2000
Last Dividend (on 12/11/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
DAVID L LEARY
Front Load Fee
4.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
2.09%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Allergan plc 4.12 k 1.79 m 6.15
Medtronic PLC 16.24 k 1.68 m 5.79
Bristol-Myers Squibb Co 16.50 k 1.52 m 5.23
Gilead Sciences Inc 9.35 k 1.36 m 4.69
UnitedHealth Group Inc 8.71 k 1.35 m 4.65
Regeneron Pharmaceuticals Inc 1.49 k 1.12 m 3.87
Boston Scientific Corp 33.24 k 840.09 k 2.89
Alkermes PLC 7.71 k 781.95 k 2.69
AstraZeneca PLC 15.87 k 747.07 k 2.57
McKesson Corp 2.74 k 718.00 k 2.47
Profile
CFS Managed Investment Fund - Global Health & Biotechnology is a unit trust incorporated in Australia. The objective of the Fund is to provide long-term capital growth by predominantly investing in companies around the world, whose primary business is in the fields of pharmaceuticals, biotechnology, medical devices, or medical services.
ADDRESS
Colonial First State Asset Mgt Ltd
11 Harbour Street
Sydney NSW 2000
Australia
PHONE
Tel: 61-2-9303-3000